Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Open-market buy Director bought 30,031 shares at an average $1.33 ($40,014)
  2. 4 Option exercise VP Finance/Prin Fin&Acct Offic acquired 30,000 shares (option exercise)
  3. 4 Open-market buy 10% owner bought 60,431,039 shares at $0.95 ($57,409,487)
  4. 4 Open-market buy Director bought 127,206 shares at an average $0.71 ($90,710)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 135,879 shares at an average $0.58 ($78,474)
  7. 4 Open-market buy Chief Medical Officer bought 280,000 shares at $0.50 ($139,888)
  8. 4 Open-market buy Director bought 51,996 shares at $0.49 ($25,478)
  9. 4 Open-market buy Director bought 3,663 shares at $0.33 ($1,203)
  10. 4 Open-market buy Chief Financial Officer bought 125,000 shares at $0.26 ($32,338)
  11. 4 Open-market buy Director bought 23,680 shares at an average $0.29 ($6,978)
  12. 4 Open-market buy Chief Medical Officer bought 595,425 shares at an average $0.32 ($188,737)
  13. 4 Open-market buy Director bought 185,200 shares at an average $0.27 ($49,989)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 17 · 339 filings